Broderick Brian C Buys 4,797 Shares of Danaher Corporation (DHR)
Broderick Brian C increased its stake in shares of Danaher Corporation (NYSE:DHR) by 9.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,815 shares of the conglomerate’s stock after buying an additional 4,797 shares during the period. Danaher Corporation accounts for 1.8% of Broderick Brian C’s holdings, making the stock its 23rd largest position. Broderick Brian C’s holdings in Danaher Corporation were worth $4,796,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Lee Danner & Bass Inc. raised its position in Danaher Corporation by 0.4% in the first quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock worth $225,000 after buying an additional 10 shares during the last quarter. Norway Savings Bank raised its position in Danaher Corporation by 0.4% in the second quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock worth $189,000 after buying an additional 10 shares during the last quarter. Rehmann Capital Advisory Group raised its position in Danaher Corporation by 0.6% in the first quarter. Rehmann Capital Advisory Group now owns 2,959 shares of the conglomerate’s stock worth $253,000 after buying an additional 19 shares during the last quarter. Alpha Windward LLC raised its position in Danaher Corporation by 0.8% in the first quarter. Alpha Windward LLC now owns 2,605 shares of the conglomerate’s stock worth $223,000 after buying an additional 21 shares during the last quarter. Finally, First Financial Corp IN raised its position in Danaher Corporation by 0.8% in the second quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock worth $230,000 after buying an additional 21 shares during the last quarter. Institutional investors own 76.56% of the company’s stock.
Danaher Corporation (NYSE DHR) traded down 0.09% during midday trading on Monday, reaching $80.94. The company’s stock had a trading volume of 658,510 shares. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.01. The firm has a market cap of $56.23 billion, a P/E ratio of 25.83 and a beta of 1.03. The firm has a 50 day moving average price of $83.93 and a 200-day moving average price of $84.29.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the business posted $0.90 EPS. On average, analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Friday, June 30th were given a dividend of $0.14 per share. The ex-dividend date was Wednesday, June 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.69%. Danaher Corporation’s dividend payout ratio is 17.83%.
A number of research firms have recently commented on DHR. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 price objective on shares of Danaher Corporation in a research note on Friday. BidaskClub lowered Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective on the stock in a research note on Friday, July 28th. Wells Fargo & Company reiterated a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Finally, Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $91.76.
In related news, insider William King sold 7,458 shares of the stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the sale, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Angela S. Lalor sold 10,815 shares of the stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the sale, the senior vice president now owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold a total of 38,623 shares of company stock worth $3,206,426 in the last quarter. 12.20% of the stock is currently owned by company insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.